http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-102254572-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2200-314 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2002-00 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-38 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-185 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-53 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-105 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-282 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-704 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-282 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-185 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-38 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-53 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L33-105 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-704 |
| filingDate | 2019-05-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2021-05-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2021-05-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-102254572-B1 |
| titleOfInvention | Composition for improving chronic obstructive pulmonary disease using an extract of Elsholtzia ciliate |
| abstract | The present invention inhibits NETosis induced by PMA (phorbol myristate acetate), and expresses IL-8, an inflammatory cytokine, in H292 cells, a bronchial epithelial cell line stimulated by CSE (cigarette smoke extract). Inhibits, and inhibits the expression of the inflammatory cytokine MIP2 (IL-8) in MH-S cells, which are mouse alveolar macrophages activated by CES, as well as invasion of BALF in CES and PPE-induced COPD animal model experiments. Scented oil extract with the activity of lowering the number of cells and neutrophils, restoring airway obstruction and alveolar destruction, and lowering the concentration of inflammatory cytokines such as IL-1β, MIP-2, IL-6, and TNF-α of BALF. Disclosed is a composition for improving chronic obstructive pulmonary disease using. |
| priorityDate | 2018-05-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 215.